Medical Procedure News

RSS

Study reveals increase in treatment admissions for drug abuse

From 1998 to 2008 there were marked changes in some patterns of substance use treatment admissions according to a study by the Substance Abuse and Mental Health Services Administration (SAMHSA). Although the concurrent abuse of both alcohol and drugs has remained widespread, the proportion of treatment admissions for the co-abuse of these substances has declined gradually yet significantly during this period - from 44 percent to 38 percent.

13 May 2010

Cognitive strategies lessen depression symptoms: Study

Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.

13 May 2010

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

Fortis Hospitals Mulund, Mumbai, performed a multiple joint replacement surgery on a 27 year old young Nigerian patient. Rebacca underwent a hip and a shoulder replacement surgery by Dr. Sachin Bhonsle, Consultant Orthopedic Surgeon, after years of suffering in pain and immobility.

13 May 2010

Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a University at Buffalo behavioral scientist achieved significant relief within four weeks of beginning treatment.

13 May 2010

RYGB surgery increases insulin activity in diabetes mellitus patients

Diabetes mellitus is a chronic metabolic disease resulted from, either decreased production of insulin or increased resistance to it from peripheral tissues or both factors combined together. While medical treatment remains the mainstay of treatment for diabetes, some surgical procedures, such as Roux-en-Y gastric bypass, have demonstrated some potential to be a treatment option for diabetes.

13 May 2010

Researchers develop new approach to immunotherapy of cancer

Harnessing the immune system is emerging as one of the most promising new ways to fight cancer. Most cancer cells are eliminated by the immune system; however, over a lifetime, a few may escape this immune surveillance and lead to tumors and metastases. Hence a formidable opportunity has been to find ways to make the immune system recognize the tumor as a foreign body and trigger a response.

13 May 2010

Robotic surgery keeps features intact in head, neck cancer removal procedures

Surgeons who perform procedures to remove head and neck cancers often work for six to eight hours on what is typically major, invasive surgery, which many times comes with facial disfigurement and debilitating side effects for the patient.

13 May 2010

Study compares outcome of popular esophageal stents in patients with dysphagia

Less than 50% of patients with esophageal carcinoma are suitable for surgery at the time of diagnosis. Most of these patients present with locally advanced or metastatic disease and/or significant comorbidities. In such circumstances, the only therapeutic option is palliative care to treat dysphagia and prevent respiratory complications secondary to aspiration. Self-expanding metal stents have been proven effective for palliation of dysphagia in patients with esophageal carcinoma, tracheo-esophageal fistulas or anastomotic leaks.

13 May 2010

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

Congenital heart defects are the most common type of major birth defect in the U.S., affecting about 25,000 babies each year. Now, a new valve being used at the University of Michigan's C.S. Mott Children's Hospital Congenital Heart Center can help patients delay or avoid multiple surgeries.

13 May 2010

Resverlogix' Phase 2 ASSERT trial dosing complete ahead of schedule

Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.

13 May 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.

13 May 2010

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System, Boston Scientific's third-generation drug-eluting stent (DES) technology.

13 May 2010

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

The trial of Dr. Jayant Patel continues. In recent evidence at the court one of the operating theatre nurses revealed under oath to the Brisbane Supreme Court how staff had tried to deter former Bundaberg-based surgeon Jayant Patel from transferring an unstable patient from the theatre to ICU, where he died. There was earlier evidence that the man was bleeding uncontrollably and also allegations that Patel urged junior doctors not to tell anyone what happened.

12 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

Risk of venous thromboembolism is low after hepatic resection in cirrhotic patients: Researchers

Hepatocellular carcinoma is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulative function. Surgical resection is the best option to cure HCC, however, surgery on cirrhotic liver may increase the risk of bleeding.

12 May 2010

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).

12 May 2010

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.

12 May 2010

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Drug-releasing stents are more effective than bare metal stents at keeping a blocked artery open after angioplasty, but the difference does not result in fewer deaths or subsequent heart attacks after the procedure, according to a review of recent studies.

12 May 2010

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.

12 May 2010

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.

12 May 2010

Medical Procedure News

Study reveals increase in treatment admissions for drug abuse

Cognitive strategies lessen depression symptoms: Study

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

RYGB surgery increases insulin activity in diabetes mellitus patients

Researchers develop new approach to immunotherapy of cancer

Robotic surgery keeps features intact in head, neck cancer removal procedures

Study compares outcome of popular esophageal stents in patients with dysphagia

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

Resverlogix' Phase 2 ASSERT trial dosing complete ahead of schedule

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Risk of venous thromboembolism is low after hepatic resection in cirrhotic patients: Researchers

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News